Patent details

Herbas

VPB

Print

EN | LT

LT - TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1FO-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF

EN - TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1FO-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 231/38
		A61K 31/415
		A61P 35/00
		A61P 37/00
		A61P 31/04
		A61P 9/00
		A61K 9/00
		A61K 9/28
		A61K 9/48

European patent
(11)	Number of the document	3080089
(13)	Kind of document	T
(96)	European patent application number	14869792.3
	Date of filing the European patent application	2014-12-10
(97)	Date of publication of the European application	2016-10-19
(45)	Date of publication and mention of the grant of the patent	2019-05-08
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2014/069487
	Date	2014-12-10

PCT application publication
(87)	Number	WO 2015/089149
	Date	2015-06-18

Priority applications
(30)	Number	Date	Country code
	201361914085 P	2013-12-10	US
	201461979619 P	2014-04-15	US

Inventors
(72)	HURD, Alexander R., US TAYLOR, Clarke B., US WANG, Jian, US ZHOU, Peng, CN

Grantee
(73)	Lycera Corporation, 2800 Plymouth Rd. NCRC Building 26, Ann Arbor, MI 48109, US

Title
(54)	TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1FO-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF
	TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1FO-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF